Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Kymera Therapeutics, Inc. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
eosinophilic asthma, kt-621, stat6 degrader, stat6, targeted protein degrader, phase 2, phase 2b, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 907092
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.